Skip to main content
. 2020 Apr 28;98(5):254–261. doi: 10.4174/astr.2020.98.5.254

Table 5. The changes in medical costs and utilizations for gastroesophageal reflux disease in the medication and surgery groups according to follow-up years.

graphic file with name astr-98-254-i005.jpg

SE, standard error.

Two-sample t-test was separately conducted for each value according to the follow-up years. Surgery and medication groups were significantly different for all values (P < 0.0001).